Publication Date
| In 2025 | 0 |
| Since 2024 | 0 |
| Since 2021 (last 5 years) | 0 |
| Since 2016 (last 10 years) | 0 |
| Since 2006 (last 20 years) | 1 |
Descriptor
| Adolescents | 1 |
| Attention Deficit… | 1 |
| Child Health | 1 |
| Children | 1 |
| Comparative Analysis | 1 |
| Drug Therapy | 1 |
| Measures (Individuals) | 1 |
| Patients | 1 |
| Questionnaires | 1 |
| Safety | 1 |
| Stimulants | 1 |
| More ▼ | |
Source
| Journal of the American… | 1 |
Author
| Ball, Roberta R. | 1 |
| Greenhill, Laurence L. | 1 |
| Jiang, Hai | 1 |
| Levine, Alan | 1 |
| Muniz, Rafael | 1 |
| Pestreich, Linda | 1 |
Publication Type
| Journal Articles | 1 |
| Reports - Research | 1 |
Education Level
Audience
Location
Laws, Policies, & Programs
Assessments and Surveys
| Conners Rating Scales | 1 |
What Works Clearinghouse Rating
Peer reviewed
Direct linkGreenhill, Laurence L.; Muniz, Rafael; Ball, Roberta R.; Levine, Alan; Pestreich, Linda; Jiang, Hai – Journal of the American Academy of Child & Adolescent Psychiatry, 2006
Objective: The efficacy and safety of dexmethylphenidate extended release (d-MPH-ER) was compared to placebo in pediatric patients with attention-deficit/hyperactivity disorder (ADHD). Method: This multicenter, randomized, double-blind, placebo-controlled, parallel-group, two-phase study included 97 patients (ages 6-17 years) with…
Descriptors: Attention Deficit Hyperactivity Disorder, Safety, Child Health, Patients
